Sonoma Pharmaceuticals Announces 1-for-9 Reverse Split of Outstanding Common Stock Nasdaq
PETALUMA, Calif., June 19, 2019– Specialty pharmaceutical company Sonoma Pharmaceuticals, Inc., today announced the timing for a 1- for-9 reverse.
Sonoma Pharmaceuticals Announces 1-for-9 Reverse Split of Outstanding Common Stock Nasdaq
PETALUMA, Calif., June 19, 2019– Specialty pharmaceutical company Sonoma Pharmaceuticals, Inc., today announced the timing for a 1- for-9 reverse.